• Sonuç bulunamadı

Pharmaceutical Technology-IV Good Manufacturing Practices

N/A
N/A
Protected

Academic year: 2021

Share "Pharmaceutical Technology-IV Good Manufacturing Practices"

Copied!
24
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

 

               

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceutical Technology-IV

Good Manufacturing Practices

 

1  

(2)

 

Drugs,

 

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   2  

are  the  mixtures  of  one  or  more  ac/ve  

substances  in  pure  form  or  together  with  

some  excipients  and  prepared  by  various  

methods  in  order  to  make  them  useful  for  

the  use  of  the  pa/ent  .    

(3)

GMP

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   3  

G

ive  me  

M

ore    

(4)

   

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   4  

     

It  is  not  enough  to  determine  only  one  method  

for  the  prepara?on  of  the  drug.  

       

 

The  important  things  for  the  prepara?on  of  drugs  

are;  

 -­‐-­‐  

Implementa?on  of  the  same  method  as    effec?ce  as  

for  each  prepara?on.  

 -­‐-­‐  

GeFng  the  same  quality  every  ?me  

       GMP  is  not  related  to  prepara?on  procedure  but  

relataed  to  quality  and  repeatability  of  prepara?on  

(5)

What  is    GMP  

Good  Manufacturing  Prac?ces  

is  that  part  of  Quality  

Assurance  which  ensures  that  Medicinal  products  

are  consistently  produced  and  controlled  to  the  

quality  standarts  appropriate  to  their  intended  use  

and  as  required  by  the  marke?ng  authorisa?on  or  

product  spesifica?on.  

(6)

Why  GMP  ?  

The  GMP  guide  has  been  created  for  

 

-­‐  Safety  

                             

-­‐  Efficacy  

 

(7)

This  system  has  been  created  to  

eliminate  the  risks  of  pharmaceu?cal  

produc?on  that  can  no  longer  be  

prevented  during  finished  product  

tes?ng.  

(8)

   

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   8  

GMP

:  

G

ood  

M

anufacturing  

P

rac/ce  

GLP

:  

G

ood  

L

aboratory  

P

rac/ce  

GCP

:  

G

ood  

C

linical  

P

rac/ce  

(9)
(10)
(11)
(12)
(13)
(14)

GMP RelatedEstablishment/Institudes

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   14  

cGMP

PIC

FDA

EMEA

ICH

WHO

(15)

Doç.  Dr.  Müge  Kılıçarslan                                                                                                                   15  

WHO: W

orld

H

ealth

O

rganization

FDA:

F

ood and

D

rug

A

dministration

EMA:

E

uropean

M

edicine

A

gency

PIC: P

harmaceutical

I

nspection

C

onvention

ICH: International Conference on Harmonization

(16)
(17)
(18)

EudraLex  -­‐  Volume  4  Good  manufacturing  

prac?ce  (GMP)  Guidelines  

18   Doç.Dr.  Müge  Kılıçarslan                                      

(19)

EudraLex  -­‐  Volume  4  Good  manufacturing  

prac?ce  (GMP)  Guidelines  

(20)

20   Doç.Dr.  Müge  Kılıçarslan                                      

(21)

21   Doç.Dr.  Müge  Kılıçarslan                                      

(22)

22   Doç.Dr. Müge Kılıçarslan

(23)

EudraLex  -­‐  Volume  4  Good  manufacturing  

prac?ce  (GMP)  Guidelines  

(24)

References  

• 

Good  Manufacturing  Prac?ces  for  Pharmaceu?cals,  

Sidney  H.  Willing,  Marcel  Dekker,  2001.  

• 

Pharmaceu?cal  Pre-­‐Approval  Inspec?ons,  guide  to  

regulatory  Success,  2  nd.  Ed,  Mar?n,  D.  Hyness,  2008.  

• 

Quality  Guidelines  

• 

ICH  Gudilines  for  Efficacy,  safety  and  quality  

• 

hap://www.picscheme.org

 

• 

haps://ec.europa.eu/health/documents/eudralex/

Referanslar

Benzer Belgeler

Nanoemulsion Preparation at different Sonication Amplitude Percentage Formulations prepared from sonication with different surfactants at various surfactant to cinnamon

Fundamental functions include the supply of medication and other health-care products of assured quality, the provision of appropriate information and advice to the

which to interpret the particle size of a powder, it is necessary to carry out a size analysis using one or more different methods. ➢ Particle size analysis methods can

Pharmakon + Poiein = Pharmacopoeia.. The therapeutically effective amount of the active ingredients, the dosage forms prepared therefrom, the excipients used are given

• Check the appropriateness of the prescription, the usual and maximum doses, the possible drug interactions and the repeatability of the prescription.. • Pharmacist must check

special pharmaceutical purposes Purified water Distillation Reverse osmosis Water for injection packaging sterilization Sterile purified water Water as ingredient

Standart dışı ve düşük kaliteli hazır betonun önlenmesi için hazır betonun üretim yerinde denetimi amacıyla Türkiye Hazır Beton Birliği (THBB) tarafından 1995

Söz konusu farklılıkların sonucu olarak kalsiyum alüminat çimentoları; dayanım kazan- ma, nihai dayanım ve dayanıklılık para- metrelerinde portland çimentolardan çok